Form 4: Protagonist Therapeutics CFO Asif Ali Reports Stock Sales and Option Exercise

Asif Ali, CFO of Protagonist Therapeutics, reports the sale of common stock and the exercise of stock options in recent transactions.

Summary

• Asif Ali, the Chief Financial Officer of Protagonist Therapeutics, reported several transactions involving the company's stock.
• On February 29, 2024, Ali sold 7,850 shares of common stock at an average price of $30.61 and 2,089 shares at $31.
• On March 1, 2024, Ali exercised a stock option for 12,000 shares at a price of $12.17 per share.
• Also on March 1, 2024, Ali sold 12,000 shares at an average price of $32.22 and 2,248 shares at an average price of $32.33.
• Following these transactions, Ali directly owns 38,397 shares of common stock and holds options for 51,750 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting insider trading activity. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company executives as it can provide insights into their perspective on the company's value.

Key Dates